Zheng Xinya, Ai Hongru, Qian Kewen, Li Guangyao, Zhang Shuyi, Zou Yitan, Lei Changhai, Fu Wenyan, Hu Shi
Department of Biomedical Engineering, College of Basic Medical Sciences, Second Military Medical University, Shanghai, China.
School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, China.
Front Immunol. 2024 Feb 26;15:1344681. doi: 10.3389/fimmu.2024.1344681. eCollection 2024.
Exosomes are small extracellular vesicles (sEVs) secreted by cells. With advances in the study of sEVs, they have shown great potential in the diagnosis and treatment of disease. However, sEV therapy usually requires a certain dose and purity of sEVs to achieve the therapeutic effect, but the existing sEV purification technology exists in the form of low yield, low purity, time-consuming, complex operation and many other problems, which greatly limits the application of sEVs. Therefore, how to obtain high-purity and high-quality sEVs quickly and efficiently, and make them realize large-scale production is a major problem in current sEV research. This paper discusses how to improve the purity and yield of sEVs from the whole production process of sEVs, including the upstream cell line selection and cell culture process, to the downstream isolation and purification, quality testing and the final storage technology.
外泌体是细胞分泌的小细胞外囊泡(sEVs)。随着sEVs研究的进展,它们在疾病的诊断和治疗中显示出巨大潜力。然而,sEV疗法通常需要一定剂量和纯度的sEVs才能达到治疗效果,但现有的sEV纯化技术存在产量低、纯度低、耗时、操作复杂等诸多问题,这极大地限制了sEVs的应用。因此,如何快速高效地获得高纯度、高质量的sEVs,并使其实现大规模生产是当前sEV研究中的一个主要问题。本文从sEVs的整个生产过程,包括上游细胞系选择和细胞培养过程,到下游的分离纯化、质量检测以及最终的储存技术,探讨了如何提高sEVs的纯度和产量。